The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Widely prescribed testosterone medications, like AndroGel, have now been shown to cause strokes, pulmonary embolisms, heart attacks, blood clots, osteonecrosis and death. A watershed study published in the Journal of the American Medical Association in November 2013 showed a dramatic increase of up to 30% in the risk of stroke, pulmonary embolism, blood clots, heart attack and death in men taking testosterone. Learn more about the JAMA study showing testosterone causes cardiovascular injuries here. This study has been supported by a second study published in January 2014. The study showed that the risk of a heart attack was significantly increased by using testosterone.

On January 31, 2014, the FDA announced that it was reconsidering the safety of testosterone therapy medications. On June 19, 2014, the FDA issued a partial labeling change for testosterone to warn about the risk of blood clots. The partial labeling change will impact testosterone lawsuits where patients suffered blood clots. On March 3, 2015, the FDA announced that testosterone labels will be changed to warn about the risks of heart attacks and strokes and also to clarify that testosterone should not be used to treat Low T or low testosterone levels associated with aging.

AndroGel and other testosterone medications do not provide adequate warnings about these risks and about the monitoring and testing necessary to minimize these risks. For this reason, our testosterone lawsuits are only filed against the manufacturers and distributors, not your physicians.

On June 6, 2014, the Judicial Panel on Multi-District Litigation ordered that all testosterone cases in federal courts will be transferred to Judge Kennelly in the Northern District of Illinois for consolidated or coordinated pretrial proceedings. The Northern District of Illinois is the home district of AbbVie and Abbott, the makers of AndroGel. In t

Our experienced AndroGel attorneys are representing men with low testosterone who have taken testosterone therapy medications, like AndroGel, that cause stroke, pulmonary embolism, blood clot, or heart attack. If you or a loved one had a stroke, pulmonary embolism, heart attack, blood clot or were diagnosed with osteonecrosis while taking AndroGel or another testosterone medication, please call  Jamie Sheller Esq at 1 800 883 2299 free consultation.

Comments are closed.